Dual versus triple therapy in treatment of hepatitis C virus (HCV)

被引：0
|
作者：
Nevine Bishai
Walid el Nabawy
Mohamed El Fiki
Mohamed Ibrahim
Nouman El Garem
机构：
[1] Cairo University Hospitals,Department of Internal Medicine, Faculty of Medicine
[2] Beni-Sueif University Hospitals,Faculty of Medicine
[3] Cairo University Hospitals,Faculty of Medicine
来源：
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷 / 3期
关键词：
Daclatasvir; Egypt; HCV; Interferon; Ribavirin; Sofosbuvir; SVR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1129 / 1135
页数：6
相关论文
共 50 条
  • [1] Dual versus triple therapy in treatment of hepatitis C virus (HCV)
    Bishai, Nevine
    El Nabawy, Walid
    El Fiki, Mohamed
    Ibrahim, Mohamed
    El Garem, Nouman
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1129 - 1135
  • [2] Evaluation of Dual Versus Triple Therapy for Hepatitis C
    Brown, Nicol D.
    Browne, Barry A.
    Kim, Christine
    Jo, Chanhee
    Sears, Dawn
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2014, 6 (06) : 270 - 276
  • [3] COMPARATIVE EFFECTIVENESS OF TRIPLE THERAPY VERSUS DUAL THERAPY FOR CHRONIC HEPATITIS C VIRUS INFECTION IN KAZAKHSTAN
    Almadiyeva, A.
    Kostyuk, A.
    Nurgozhin, T.
    VALUE IN HEALTH, 2013, 16 (07) : A345 - A345
  • [4] Triple therapy in the Hepatitis C virus
    Fernandez Castroagudin, Javier
    Molina Perez, Esther
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (10) : 634 - 634
  • [5] Triple Therapy for Chronic Hepatitis C Virus (HCV) Infection: A Comparison of Outcomes in Patients with Minimal versus Advanced Fibrosis
    Ayres, Lauren E.
    Langness, Jacob
    Tise, Sarah
    Burton, James R.
    Everson, Gregory T.
    HEPATOLOGY, 2013, 58 : 1163A - 1163A
  • [6] Analysis of Early Treatment Discontinuations in Hepatitis C (HCV) Triple Therapy Era
    Shnitser, Anastasia
    Chan, Doris H.
    Herrine, Steven
    Fenkel, Jonathan M.
    GASTROENTEROLOGY, 2013, 144 (05) : S981 - S981
  • [7] Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment
    James, Paul Damien
    Wong, David K. H.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (01): : 31 - 35
  • [8] COST-EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH TELAPREVIR/PEGYLATED INTERFERON ALPHA/RIBAVIRIN TRIPLE THERAPY VERSUS WAITING FOR NEW REGIMENS IN FRANCE
    Lee, A.
    Granados, D.
    Hulbert, E.
    McGarry, L.
    Fleischmann, J.
    VALUE IN HEALTH, 2013, 16 (07) : A497 - A497
  • [9] DOUBLE VERSUS TRIPLE THERAPY IN CHRONIC HCV HEPATITIS - A SYSTEMATIC REVIEW
    Jurchis, A. R.
    Sirli, R.
    Sporea, I.
    Bota, S.
    Sendroiu, M.
    Danila, M.
    Popescu, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S442 - S442
  • [10] Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
    Habchi, Jackie
    Thomas, Aurielle M.
    Sprecht-Walsh, Sophie
    Arias, Elenita
    Bratberg, Jeffrey
    Hurley, Linda
    Hart, Susan
    Taylor, Lynn E.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10):
12345